RISK OF FETAL GROWTH-RETARDATION AS A RESULT OF MATERNAL HYPERTENSION - PREPARATION TO A TRIAL ON ANTIHYPERTENSIVE DRUGS

被引：15

作者：

BREART, G

RABARISON, Y

PLOUIN, PF

SUREAU, C

RUMEAUROUQUETTE, C

机构：

[1] HOP ST JOSEPH,SERV PROF MENARD,F-75674 PARIS 14,FRANCE

[2] CLIN UNIV BAUDELOCQUE,PARIS,FRANCE

来源：

DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS | 1982年 / 4卷

关键词：

D O I：

10.1159/000457366

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：116 / 123

页数：8

共 19 条

[1]

ARIAS F, 1979, OBSTET GYNECOL, V53, P489

[2]

BREART G, 1979, ARCH FR PEDIAT, V34, pR221

[3]

BUTLER NR, 1969, PERINATAL PROBLEMS

[4]

CHAMBERLAIN G, 1978, BRIT BIRTH 1970, V2

[5]

Friedman EA, 1977, PREGNANCY HYPERTENSI

[6] RANDOMIZED COMPARISON OF METHYLDOPA AND OXPRENOLOL FOR TREATMENT OF HYPERTENSION IN PREGNANCY [J].

GALLERY, EDM ;

SAUNDERS, DM ;

HUNYOR, SN ;

GYORY, AZ .

BRITISH MEDICAL JOURNAL, 1979, 1 (6178) :1591-1594

[7] PREDICTION OF LOW BIRTHWEIGHT AND PREMATURITY BY A MULTIPLE REGRESSION ANALYSIS WITH MATERNAL CHARACTERISTICS KNOWN SINCE BEGINNING OF PREGNANCY [J].

KAMINSKI, M ;

GOUJARD, J ;

RUMEAURO.C .

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1973, 2 (02) :195-204

[8]

LEATHER HM, 1968, LANCET, V2, P488

[9]

LELLOUCH J, 1976, REV EPIDEMIOL SANTE, V24, P201

[10] HYPERTENSION DURING PREGNANCY, WITH AND WITHOUT SPECIFIC HYPOTENSIVE TREATMENT .1. PERINATAL FACTORS AND NEONATAL MORBIDITY [J].

MUTCH, LMM ;

MOAR, VA ;

OUNSTED, MK ;

REDMAN, CWG .

EARLY HUMAN DEVELOPMENT, 1977, 1 (01) :47-57

← 1 2 →